HOME >> BIOLOGY >> NEWS
New anthrax inhibitor could combat antibiotic-resistant strains

Note: This press release was updated on August 23, 2006.

Troy, N.Y. - In a new approach to treating anthrax exposure, a team of scientists has created an inhibitor designed to tackle the growing threat of antibiotic-resistant strains. Reporting in this week's online early edition of the Proceedings of the National Academy of Sciences (PNAS), researchers from Rensselaer Polytechnic Institute and the University of Toronto describe the new anthrax toxin inhibitor, which performed successfully in both laboratory and animal tests.

Anthrax toxin, secreted by the anthrax bacterium, is made of proteins and toxic enzymes that bind together to inflict damage on a host organism. Rather than targeting the anthrax bacterium or toxin - the approach taken by the majority of current therapies - the new inhibitor blocks the receptors where anthrax toxin attaches in the body. And because the nanoscale assembly of molecules is designed to bind to multiple sites on the host receptor, it is naturally more potent.

The new approach led to a 50,000-fold increase in potency in cell culture, and the inhibitor protected rats from anthrax toxin in the study. The general concept also could be applied to designing inhibitors for other pathogens, including SARS, influenza, and AIDS, the researchers note.

ncreased research on possible therapeutics and vaccines to treat toxins that could be used as biological weapons. The current treatment for anthrax exposure is antibiotics, but the emergence of antibiotic-resistant strains calls for new approaches to designing therapeutics for bioterrorism agents, according to Ravi Kane, the Merck Associate Professor of Chemical and Biological Engineering at Rensselaer and corresponding author of the PNAS paper.

Pathogens such as anthrax can become resistant to antibiotics through natural processes, but resistance also can be engineered intentionally. The team's new approach co
'"/>

Contact: Jason Gorss
gorssj@rpi.edu
518-276-6098
Rensselaer Polytechnic Institute
28-Aug-2006


Page: 1 2 3

Related biology news :

1. Taming the anthrax threat
2. New finding points way to foiling anthraxs tricks
3. UGA researchers discover cell-wall carbohydrate that is crucial to anthrax bacterium
4. Combating anthrax: Results of study published this month as researchers look for a better vaccine
5. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
6. Patent awarded for LSUHSC-developed peptide that blocks lethal toxins of anthrax
7. Scientists design potent anthrax toxin inhibitor
8. Newly discovered protein kills anthrax bacteria by exploding their cell walls
9. Driver of anthrax toxicity could lead to late-stage therapy
10. UCSD study finds anthrax toxins also harmful to fruit flies
11. UCF, NIH study: Effective, safe anthrax vaccine can be grown in tobacco plants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... ... AMRI, a global contract research, development and manufacturing organization ... quality of life, will now be offering its impurity solutions as a stand-alone ... for all new drug products, including the finalization of ICH M7 earlier this ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back ... 8th June 2018 in San Francisco, CA. The Summit brings together current and former ... CEOs, board directors and government officials from around the world to address key issues ...
(Date:10/11/2017)... Austin, TX (PRWEB) , ... October 11, 2017 ... ... in August compared the implantation and pregnancy rates in frozen and fresh ... the contribution of progesterone and maternal age to IVF success. , After comparing ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
Breaking Biology Technology:
Cached News: